DrugCard

DrugCard is a pharmacovigilance platform that automates the monitoring of medical literature for drug safety teams. It runs scheduled searches across global databases, including Medline/PubMed and Excerpta Medica (Embase), and across local and regional journals that those databases often miss. Results from multiple sources land in one deduplicated review queue. AI assesses each publication for safety relevance before a person reads it, highlighting suspected adverse reactions and product mentions so reviewers can concentrate on the articles that matter. Non English publications are translated automatically and summarized, and every search and screening decision is documented to support audits. The vendor states that the platform covers more than 100 languages and over 2,300 local journals, and that a new country can be added in roughly two weeks. The product is built for contract research organizations, marketing authorization holders and freelance pharmacovigilance specialists. CROs can take on more projects without reading journals manually, while marketing authorization holders can bring local literature screening in house. The vendor also offers related pharmacovigilance services, such as help preparing risk management plans. DrugCard does not publish prices. Access is arranged through a demo request, and existing customers sign in through a login link on the site. The company was founded by two brothers, one of whom worked as a pharmacovigilance specialist before starting it.